Paul McGale

• Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

  Taylor C. et al, (2017), J Clin Oncol, 35, 1641 - 1649

• Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.

  Rehammar JC. et al, (2017), Radiother Oncol, 123, 299 - 305

• A cardiac contouring atlas for radiotherapy.

  Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422

• Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

  Ramroth J. et al, (2016), Int J Radiat Oncol Biol Phys, 96, 736 - 747

• Can Observational Data Replace Randomized Trials?

  McGale P. et al, (2016), J Clin Oncol, 34, 3355 - 3357

• Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries.

  Henson KE. et al, (2016), J Clin Oncol, 34, 803 - 809

• Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

  EBCTCG (Early Breast Cancer Trialists' Collaborative Group) None. et al, (2014), Lancet, 383, 2127 - 2135

• Effect of radiotherapy after mastectomy and axillary dissection on recurrence and breast cancer mortality: Meta-analysis of individual patient data from randomised trials

  McGale P. et al, (2014), EUROPEAN JOURNAL OF CANCER, 50, S102 - S102

• Erratum: Cardiac dose from tangential breast cancer radiotherapy in the year 2006 (International Journal of Radiation Oncology Biology Physics (2008) 72 (501-507))

  Taylor CW. et al, (2013), International Journal of Radiation Oncology Biology Physics, 87

• Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians.

  Mathews JD. et al, (2013), BMJ, 346

• Risk of ischemic heart disease in women after radiotherapy for breast cancer.

  Darby SC. et al, (2013), N Engl J Med, 368, 987 - 998

• Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer.

  Henson KE. et al, (2013), Br J Cancer, 108, 179 - 182

• A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

  Lim SS. et al, (2012), Lancet, 380, 2224 - 2260

• Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study.

  Sakata R. et al, (2012), BMJ, 345

• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2012), Lancet, 379, 432 - 444

• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 1707 - 1716

• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 771 - 784

• Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden.

  McGale P. et al, (2011), Radiother Oncol, 100, 167 - 175

• Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden

  McGale P. et al, (2011), Radiotherapy and Oncology, 100, 167 - 175

• Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001.

  Taylor CW. et al, (2011), Radiother Oncol, 100, 176 - 183

• Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001

  Taylor CW. et al, (2011), Radiotherapy and Oncology, 100, 176 - 183

• Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.

  Rahimi K. et al, (2011), BMJ, 342

• Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2010), J Natl Cancer Inst Monogr, 2010, 162 - 177

• A Dose-response Relationship for the Incidence of Radiation-related Heart Disease

  Darby SC. et al, (2010), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78, S49 - S50

• Effect of statins on ventricular arrhythmic events: a collaborative meta-analysis of randomised controlled trials

  Rahimi K. et al, (2009), EUROPEAN HEART JOURNAL, 30, 591 - 591

• Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials

  Rahimi K. et al, (2009), EUROPEAN HEART JOURNAL, 30, 450 - 451

• Estimating cardiac exposure from breast cancer radiotherapy in clinical practice.

  Taylor CW. et al, (2009), Int J Radiat Oncol Biol Phys, 73, 1061 - 1068

• Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them

  Gray A. et al, (2009), BMJ (Online), 338, 215 - 218

• Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them.

  Gray A. et al, (2009), BMJ, 338

• Cardiac doses from Swedish breast cancer radiotherapy since the 1950s.

  Taylor CW. et al, (2009), Radiother Oncol, 90, 127 - 135

• Cardiac dose from tangential breast cancer radiotherapy in the year 2006.

  Taylor CW. et al, (2008), Int J Radiat Oncol Biol Phys, 72, 501 - 507

• Commentary: A dose-response relationship for radiation-induced heart disease--current issues and future prospects.

  McGale P. and Darby SC., (2008), Int J Epidemiol, 37, 518 - 523

• Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

  Kaufmann M. et al, (2007), Ann Oncol, 18, 1927 - 1934

• Cardiac exposures in breast cancer radiotherapy: 1950s-1990s.

  Taylor CW. et al, (2007), Int J Radiat Oncol Biol Phys, 69, 1484 - 1495

• The Early Breast Cancer Trialists' Collaborative Group: A brief history of results to date

  Darby S. et al, (2007)

• Cardiac irradiation in breast radiotherapy

  Taylor CW. et al, (2007), CLINICAL ONCOLOGY, 19, S3 - S3

• Long-term mortality from heart disease after radiotherapy for early breast cancer

  Darby SC. et al, (2007), RADIATION RESEARCH, 167, 349 - 349

• Dosimetry based on radiotherapy treatment planning

  Taylor CW. et al, (2007), Radiation Research, 167

• The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome

  Darby S. et al, (2006), RADIOTHERAPY AND ONCOLOGY, 81, S10 - S10

• Heart and coronary artery doses from breast radiotherapy

  Taylor C. et al, (2006), RADIOTHERAPY AND ONCOLOGY, 81, S283 - S283

• Effects of radiotherapy and surgery for early breast cancer - Authors' reply

  Darby S. et al, (2006), Lancet, 367, 1654 - 1655

• Cardiac risks of breast-cancer radiotherapy: a contemporary view.

  Taylor CW. et al, (2006), Clin Oncol (R Coll Radiol), 18, 236 - 246

• The 2006 worldwide overview of the effects of local treatments for early breast cancer on long-term outcome

  McGale P. et al, (2006), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 66, S2 - S3

• Previous heart disease and risk of radiation-induced heart disease in women with early breast cancer.

  Darby S. et al, (2006), BREAST CANCER RESEARCH AND TREATMENT, 100, S199 - S200

• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

  Clarke M. et al, (2005), Lancet, 366, 2087 - 2106

• Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.

  Darby SC. et al, (2005), Lancet Oncol, 6, 557 - 565

• Erratum: Low doses of ionizing radiation and circulatory diseases: A systematic review of the published epidemiological evidence (Radiation Research (2005) 163, 3 (247-257))

  McGale P. and Darby SC., (2005), Radiation Research, 163

• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2005), Lancet, 365, 1687 - 1717

• Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence.

  McGale P. and Darby SC., (2005), Radiat Res, 163, 247 - 257

• Mortality from cardiovascular disease after radiotherapy for breast cancer in 298,885 women registered in the SEER cancer registries

  Darby S. et al, (2004), BREAST CANCER RESEARCH AND TREATMENT, 88, S18 - S18

• Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women.

  Darby S. et al, (2003), BMJ, 326, 256 - 257

• Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.

  Boultwood J. et al, (2000), Blood, 96, 358 - 361

• Early breast cancer: 20-year risks if endocrine treatment stops at 5 years

  Pan H. et al, New England Journal of Medicine

Recent Publications

• Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials.

  Taylor C. et al, (2017), J Clin Oncol, 35, 1641 - 1649

• Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.

  Rehammar JC. et al, (2017), Radiother Oncol, 123, 299 - 305

• A cardiac contouring atlas for radiotherapy.

  Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422

• Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

  Ramroth J. et al, (2016), Int J Radiat Oncol Biol Phys, 96, 736 - 747

• Can Observational Data Replace Randomized Trials?

  McGale P. et al, (2016), J Clin Oncol, 34, 3355 - 3357